BUY MBP ADALIMUMAB AMAB 40MG PFS BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Medicine name: Adalimumab
Brand name: Humira or biosimilar equivalents

I would like to explain your medicine called adalimumab in detail so you clearly understand why adalimumab has been prescribed, how adalimumab works, how adalimumab is given, and the important safety points while you are receiving adalimumab. Please take your time with this information and feel free to ask questions if anything is unclear.

Adalimumab is a targeted immune-modulating medicine used to treat a range of chronic inflammatory and autoimmune conditions. These include rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn?s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and some eye and skin inflammatory conditions. Adalimumab is not a steroid and not a traditional pain medicine. Adalimumab works by calming an overactive immune system.

Adalimumab works by blocking a specific inflammatory protein in the body called tumour necrosis factor alpha, often referred to as TNF-alpha. TNF-alpha plays a major role in driving inflammation, pain, swelling, and tissue damage in autoimmune diseases. In people with these conditions, too much TNF-alpha is produced. By blocking TNF-alpha, adalimumab reduces inflammation, relieves symptoms, slows disease progression, and helps protect joints, organs, skin, or bowel from long-term damage.

Adalimumab is given as an injection under the skin, known as a subcutaneous injection. Adalimumab is usually injected into the thigh or abdomen. Depending on your condition, adalimumab may be given every two weeks or weekly. Some patients or carers are taught how to administer adalimumab at home, while others may receive adalimumab in a clinic setting. It is important to rotate injection sites and avoid injecting into areas that are bruised, sore, or inflamed.

Adalimumab must be taken exactly as prescribed. Try to take adalimumab on the same day each week or fortnight to maintain steady levels in your body. If you miss a dose of adalimumab, contact your healthcare provider for advice on when to take the next dose. Do not double dose adalimumab.

Before starting adalimumab, blood tests are required to screen for infections, particularly tuberculosis and hepatitis B. Adalimumab can weaken the immune system, and these infections can become serious if not identified before treatment. You may also have regular blood tests while on adalimumab to monitor your immune system and overall health.

Because adalimumab suppresses part of the immune system, it can increase the risk of infections. While taking adalimumab, it is very important to seek medical advice if you develop symptoms such as fever, chills, persistent cough, shortness of breath, night sweats, unexplained weight loss, burning when passing urine, or any signs of infection. If you feel unwell, it is safer to report symptoms early rather than wait.

Common side effects of adalimumab include injection site reactions such as redness, swelling, itching, or pain. These reactions are usually mild and improve with time. Other common side effects include headache, fatigue, mild nausea, and muscle or joint aches.

Less common but serious side effects of adalimumab include severe infections, allergic reactions, and blood disorders. Seek urgent medical attention if you experience chest tightness, difficulty breathing, severe rash, swelling of the face or lips, unexplained bruising, or persistent fever. Adalimumab may also slightly increase the risk of certain cancers, particularly lymphomas and skin cancers, especially with long-term use. Regular medical review is important while on adalimumab.

Live vaccines must not be given while you are receiving adalimumab. Always inform your doctor, pharmacist, or nurse that you are on adalimumab before receiving any vaccinations. Inactivated vaccines are usually safe, but this should always be confirmed first.

Adalimumab should be used with caution in people with heart failure, multiple sclerosis, or other nerve disorders. Make sure your healthcare team is aware of your full medical history before and during adalimumab treatment.

Adalimumab is sometimes used during pregnancy and breastfeeding, but this is assessed carefully by specialists based on benefits and risks. If you are pregnant, planning pregnancy, or breastfeeding, this must be discussed before continuing adalimumab.

It is important not to stop adalimumab suddenly without medical advice. Stopping adalimumab abruptly can lead to a flare of your condition and worsening symptoms. If adalimumab needs to be stopped or changed, this should be done under close medical supervision.

In summary, adalimumab is a powerful targeted medicine that reduces inflammation by blocking TNF-alpha and helps control autoimmune and inflammatory diseases. Safe and effective use of adalimumab depends on taking adalimumab as prescribed, monitoring for infections, attending regular check-ups, and reporting symptoms early. If you have any concerns or questions about adalimumab at any stage of your treatment, please raise them so your healthcare team can support you and keep your treatment safe.